This year marks the tenth anniversary of UDG Healthcare’s acquisition of Sharp in the US, specifically the Allentown and Conshohocken facilities. Being part of UDG Healthcare has allowed us to invest in the latest ideas, processes and technologies keeping us right at the forefront of the pharmaceutical packaging industry.
To mark the occasion CEO Brendan McAtamney, accompanied by some of Sharp’s senior executive team, visited our blistering Centre of Excellence in Conshohocken, to speak with staff there and to take a tour to see first-hand the production lines in operation. Brendan also took the time to acknowledge those people who are the amongst the longest serving members of staff in the UDG Group, a number of whom have over 40 years of service.
Since 2008, Sharp has continued to invest in people, facilities, equipment and infrastructure. Sharp is acknowledged industry-wide as leaders in implementing serialized solutions for our clients, a position which has been made possible by significant on-going investment by UDG in both expertise and serialization equipment and technology at each of our packaging facilities. In April of 2016, we completed the fit out of our Biotech Center of Excellence in our Allentown campus, which offers services and capacity focused on the secondary packaging of injectables. In 2017, the acquisition of a state-of-the-art packaging facility in Bethlehem, PA from Daichi Sankyo, has allowed Sharp to build out a world-class Clinical facility offering our clients both greater scale and a broader service portfolio in supporting their clinical trials. Late in 2017, we marked the implementation of our 50th serialization line, well ahead of the DSCSA and FMD regulatory deadlines in 2018 and 2019. We are now well in excess of that number, and we now have serialized lines in every Sharp facility, in readiness for legislative requirements in the US and Europe.